ANDA 61450, held by Apothecon. Oxacillin Sodium.
As of Nov 15, 2026, ANDA 61450 (Oxacillin Sodium), held by Apothecon, was not approved, with 0 approved supplements and 0 published complete response letters.
| Oxacillin SodiumEQ 500MG BASE · capsule;oral | Oxacillin Sodium | Discontinued |
| Oxacillin SodiumEQ 250MG BASE · capsule;oral | Oxacillin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
